ARCH Venture Partners

Activity from announced rounds

Activity in this selectionUndisclosed

ARCH Venture Partners creates and backs companies built on scientific discoveries, with a healthcare focus on technologies that prevent, detect and treat disease.

The firm works through company formation as well as financing, using a network of partners to translate science into an operating business. It sizes capital to the development requirements, with investments ranging from very early commitments to hundreds of millions of dollars per company.

Its long-term model accommodates scientific programmes that need substantial development before commercial scale. Founders and researchers can engage around the creation of a company, rather than waiting until a conventional growth-stage investment case is established.

Sources
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$310M
3 disclosed · full round size, not this investor’s share

By stage

Undisclosed3

By primary sector

Biotech3

By country

Sweden1
United Kingdom1
United States1

Rounds

3 in this selection
LifeMine Therapeutics

Develops fungal genome-derived therapeutics for organ transplant rejection

$263MSeries D+Series E
Role not disclosed
Moleculent

Decodes cellular networks to advance human health

$20MUndisclosed
Role not disclosed
Lightcast

Develops functional single-cell analysis tools and platforms for life science research

$27MUndisclosed
Role not disclosed